Among all proposed longevity interventions, caloric restriction (CR) has the most solid evidence base. It reliably extends lifespan in yeast, roundworms, fruit flies, mice, rats, and rhesus monkeys. The two-year CALERIE human trial provides the strongest evidence yet that CR improves aging biomarkers in people, too.
## The Molecular Mechanisms
Caloric restriction doesn’t work simply by reducing body weight. It activates multiple longevity-associated pathways:
**mTOR inhibition**: reduced amino acid and insulin signaling suppresses mTOR, activating autophagy — the cellular process that degrades damaged proteins and organelles.
**AMPK activation**: lower energy availability raises the AMP/ATP ratio, activating AMPK, which promotes mitochondrial biogenesis and fat oxidation.
**Sirtuin activation**: CR increases the NAD⁺/NADH ratio, activating sirtuin deacetylases that regulate metabolism, inflammation, and DNA repair.
**IGF-1 reduction**: lower caloric intake reduces growth hormone/IGF-1 signaling, associated with longevity phenotypes across species.
## The CALERIE Trial
The thorough Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trial is the largest human RCT of caloric restriction. 218 healthy adults were randomized to a 25% CR target (participants achieved approximately 12%) or a control group, followed for two years.
Results: participants in the CR group lost approximately 10% body weight (predominantly fat mass); epigenetic biological age (PhenoAge) improved by 2–3 years; cardiometabolic markers (blood pressure, lipids, fasting glucose) improved significantly; inflammatory markers (TNF-α, IL-6, CRP) fell substantially; and quality of life measures showed no significant deterioration. See the [CALERIE website](https://calerie.duke.edu/) and the [2023 Nature Aging paper](https://www.nature.com/articles/s43587-023-00431-3).
## Intermittent Fasting Approaches
Sustained 20–25% caloric restriction is difficult to maintain long-term. Intermittent fasting protocols offer more practical alternatives:
**16:8 time-restricted eating**: an 8-hour eating window, 16-hour fast. Even without reducing total calories, TRE improves insulin sensitivity and circadian alignment.
**5:2 fasting**: 5 days of normal eating, 2 days of approximately 500 kcal. Weight loss outcomes comparable to continuous CR with better adherence in most trials.
**Alternate-day fasting (ADF)**: alternating between normal and heavily restricted days. Strong mouse evidence; human studies show significant metabolic improvements but lower long-term compliance.
## Blue Zone Dietary Patterns
The [Blue Zones](https://www.bluezones.com/) — five regions with the world’s highest centenarian densities (Okinawa, Ikaria, Sardinia, Nicoya Peninsula, Loma Linda) — have different cuisines but share core dietary features: predominantly plant-based; limited animal protein; minimal ultra-processed foods; natural portion control embedded in culture; and regular communal meals.
These patterns align well with what CR research predicts should be beneficial: low caloric density, high nutrient quality, and eating patterns that support metabolic health without requiring explicit restriction.
For related reading, see [Hallmarks of Aging](https://sunqi.org/aging-biology-hallmarks-en/) and [Rapamycin and Longevity](https://sunqi.org/rapamycin-longevity-en/).
—
